Crossmark

Low doses of gemtuzumab ozogamicin in adults diagnosed with acute myeloid leukaemia

Crossref DOI link: https://doi.org/10.1016/j.medcle.2021.09.001

Published Print: 2021-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Peña Domingo, Marta

Vives Polo, Susana

Garrido Díaz, Ana

Coll Jordà, Rosa

Ribera Santasusana, J.M.

Ferrá Coll, Christelle
Funding

Funding for this research was provided by:

Generalitat de Catalunya
License Information

Text and Data Mining valid from 2021-10-01
More Information

This article is maintained by: Elsevier

Article Title: Low doses of gemtuzumab ozogamicin in adults diagnosed with acute myeloid leukaemia

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2021.09.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2020.07.033

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.